Inspire Medical Systems, Inc.
Financials
Valuation Metrics
Inspire Medical Systems, Inc.'s Market Cap is $2.21B. At end of 2025 it was $2.67B. Ranked #1992 of 3,121 in US market (top 64%), #1236 of 1,658 on NYSE (top 75%), #118 of 205 in Health Care Equipment & Services (top 58%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $2.21B | US#1,992/3,121 Sec#118/205 |
| Revenue | $899M | US#1,934/3,121 Sec#118/205 |
| Net Income | $135M | US#1,497/3,121 Sec#74/205 |
| Total Assets | $926M | US#2,510/3,121 Sec#132/205 |
| Net Assets | $826M | US#1,901/3,121 Sec#101/205 |
| Employees | 1,333 | US#1,886/3,121 Sec#125/205 |
| Value | ||
| P/E | 16.39x | US#814/3,121 Sec#14/205 |
| P/B | 2.68x | US#1,557/3,121 Sec#81/205 |
| PEG | 0.11x | US#213/3,121 Sec#8/205 |
| P/S | 2.46x | US#1,435/3,121 Sec#98/205 |
| EV/EBITDA | 25.45x | US#2,075/3,121 Sec#101/205 |
| FCF Yield | 5.29% | US#1,307/3,121 Sec#60/205 |
| Profitability | ||
| ROE | 16.36% | US#793/3,121 Sec#35/205 |
| ROA | 14.58% | US#236/3,121 Sec#14/205 |
| Op. Margin | 6.02% | US#1,906/3,121 Sec#101/205 |
| Revenue Growth | 4.35% | US#1,874/3,121 Sec#140/205 |
| Earnings Growth | 154.22% | US#198/3,121 Sec#10/205 |
| Financial Health | ||
| Debt Ratio | 12.16% | US#138/3,121 Sec#8/205 |
| Total Debt | $29M | US#2,702/3,121 Sec#163/205 |
| FCF | $117M | US#1,669/3,121 Sec#97/205 |
| Cash | $128M | US#2,054/3,121 Sec#125/205 |
| Current Ratio | 8.55x | US#304/3,121 Sec#20/205 |
| Net Debt/EBITDA | -1.19x | US#258/3,121 Sec#20/205 |
| Performance | ||
| 1Y Return | -7.90% | US#2,087/3,121 Sec#143/205 |
| 1M Return | 24.51% | US#48/3,121 Sec#11/205 |
| From 52W High | -47.76% | US#2,734/3,121 Sec#178/205 |
| 1Y MDD | -72.19% | US#2,991/3,121 Sec#191/205 |
| Trading | ||
| Volume | 1,301,310 shares | US#2,078/3,121 Sec#147/205 |
| Trading Value | $99M | US#1,533/3,121 Sec#110/205 |
| Per Share | ||
| EPS | $4.69 | US#728/3,121 Sec#41/205 |
| BPS | $28.65 | US#926/3,121 Sec#53/205 |
Company Info
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.